最高のHIV検査医師 - トップ16名の医師

Dr. Pichayanith Sroysuwan, M.D., M.Sc. (Anti-Aging & Regenerative Medicine, 2023–present), is a rehabilitation-trained physician. He specializes in lifestyle, anti-aging, regenerative, and personalized medicine. He practices at Foresta & Morning, Cplus Private Hospital, UMC Wellness, WIH Hospital, and Eden/Wellu.

Accreditations: American Board of Anti-Aging & Regenerative Medicine (ABAARM, 2024) and American Board of Laser Surgery (ABLS Renovia, 2024). Advanced training includes aesthetic dermatology and regenerative medicine (Mae Fah Luang, 2022), practical stem cell therapy (2022), chelation therapy (2023), high laser therapy (2019–2021), NAD+ therapy (certified 2023), and myofascial release (AHG).

Experience: Rehabilitation Medicine residency and medical practice at Srinagarind Hospital, Khon Kaen University (2019–2022). Telemedicine consultant for Raksa/Doctor Anywhere (2020–2022). Contributor to COVID-19 programs ThaiRod and COM COVID (Royal College of Family Physicians). Head of Medicine Delivery Services. Public health educator and moderator.

学歴および専門資格

• 学士号および修士号： アクデニズ大学医学部、1990年／1996年
• 博士号／医学専門資格： 泌尿器科学、アクデニズ大学、1997年／2002年
• 准教授／教授： 泌尿器科学、ハッラーン大学、2012年／2013年
• 教授： 泌尿器科学、イスタンブール・ゲリシム大学医療科学部、2019年／2023年

職歴

• 研究員： アクデニズ大学医学部泌尿器科、アンタルヤ（1997年／2002年）
• 泌尿器科専門医： アクデニズ大学医学部泌尿器科、アンタルヤ（2002年3月／2002年10月）
• 講師： ハッラーン大学医学部泌尿器科、シャンルウルファ（2003年／2006年）
• 准教授： ハッラーン大学医学部泌尿器科、シャンルウルファ（2006年／2010年）
• 准教授： ハッラーン大学医学部泌尿器科、シャンルウルファ（2012年／2013年）
• 准教授： アンタルヤ州保健省教育研究病院泌尿器科、アンタルヤ（2013年／2018年）
• 准教授： メモリアル・アンタルヤ病院泌尿器科、アンタルヤ（2018年／2019年）
• 教授： メモリアル・アンタルヤ病院泌尿器科、アンタルヤ・イスタンブール・ゲリシム大学医療科学部（2019年／2023年）
• 教授： メディカルパーク・アンタルヤ病院（2023年／現在）

国際経験

• ベルリン大学シャリテ病院 – 泌尿器科研修（2006年2月1日～3月31日、ドイツ・ベルリン）
• アクデニズ大学医学部泌尿器科 – 腹腔鏡手術に関する卒後教育、内視鏡泌尿器科学会（2008年5月1日～6月12日、トルコ・アンタルヤ）

学術団体会員資格

• トルコ泌尿器科学会
• トルコ男性学会
• トルコ内視鏡泌尿器科学会
• トルコ医師会
• 欧州泌尿器科学会
• 内視鏡泌尿器科学会
• 泌尿器外科学会
• ユーラシア泌尿器腫瘍学会
• トルコ小児泌尿器科学会
• TÜYK能力認定証
• 「腹腔鏡泌尿器科の最新の進歩」および「尿動態学および神経泌尿薬理学」（2000年10月8日、イズミル）
• IRCAD腹腔鏡泌尿器科上級コース修了証（2008年2月13日～15日）
• 腹腔鏡トレーニングプログラム修了証（内視鏡泌尿器科学会、2008年、アンタルヤ）
• 実験動物使用資格証明書（2009年1月26日～2月4日）

Dr. Sitthisak Dhammawiatnukul, MD, ABAARM, specializes in Anti-Aging & Regenerative Medicine and Preventive Medicine. His focus areas include Cell Therapy, Aesthetic Medicine, Men’s Health, Gut Health, Hormone Management, and Detox. He practices at Harmony Life Center (2023–present). He also serves as Medical Advisor at Bio Sky Clinic (2010–present).

Accreditations include the A4M Certificate in Anti-Aging and Regenerative Medicine (2011). He is an ISCT member with specialized certification in mesenchymal stem cells (MSCs). He attended the ISCT Annual Meeting in 2016. He completed the Thai Chelation Therapy Association Workshop, Level 17. He also holds certificates of attendance from A4M, the Thai Society of Cosmetic Dermatology and Surgery, the Thai Association of Cell Therapy, and the American Academy of Anti-Aging and Regenerative Medicine.

Training includes non-surgical MSC therapy for knee rejuvenation. He has additional training in gut health, hormone management, and detox. He earned his MD from Chulalongkorn University and a BSc in Medical Technology from Mahidol University. He also holds a medical training certificate from 2003.

Dr. Natthaphon Suwan, M.D., M.Sc., ABAARM, focuses on Anti-Aging & Regenerative Medicine. He earned his M.D. from Chiang Mai University in 2012. He completed an M.Sc. in Anti-Aging & Regenerative Medicine at Dhurakij Pundit University in 2019. He also received a Master of Management in Health from Mahidol University in 2020. Languages: Thai and English.

Board certifications: WOSAAM Board Diploma (2018); ABAARM/A4M (2019); Thai Board of Preventive Medicine, Public Health (2020). Professional memberships: WOSAAM, A4M, PMAT, CMAT, ACTTHAI, and TIMA.

Current practice: BAAC (2019–present), Vejthani Q Life (2019–present), and UM The Exclusive Health Clinic (2020–present). Previous roles: Vibharam Hospital and World Medical Hospital. Clinical interests: IV therapies, ozone therapy, colon hydrotherapy, male hormones and TRT, PRP, stem cells, genetic cancer risk and NK cell therapy, food intolerance testing, and personalized supplementation. Additional training: A4M (2018–2019), CMAT (2019), ACTTHAI (2019), and H.E.A.T. (2020).

医師は19 Mayıs Universityで医学教育を修了し、S.B Heybeliada G.H.G.C. Teaching and Research Hospitalでレジデンシーを完了しました。トルコの複数の都市でのキャリアを経て、現在はHisar Intercontinental Hospitalで診療を行っています。医師は特に進行期COPDおよび肺気腫患者に対する診断および介入的気管支鏡検査を専門としています。医療の関心分野には、睡眠障害、喘息とアレルギー、COPD、結核、禁煙、肺癌、集中治療が含まれます。

医学的関心分野

• 高血圧
• 高脂血症
• 甲状腺疾患
• 糖尿病および血管の問題
• 慢性疾患のフォローアップ
• 病因学 - 診断研究

教育:

学士: イスタンブール大学イスタンブール医学部

専門: イスタンブール大学イスタンブール医学部

修士: オカン大学健康管理学

訓練および勤務機関

ヒサールインターコンチネンタル病院

コズヤタギ中央病院

トルコ新聞病院

ヤシャル病院

メディカルメディスンセンター

カスンパサ軍病院

バイラムパシャ州立病院

イスタンブール医学部

バルティン、エリバシュ健康センター

ガリア・グリサル＝ソエン博士は、小児感染症に特化した経験豊富で知識豊富な医師であり、ダナ＝ドウェク小児病院の小児感染症サービスのディレクターです。彼はマルゼ・バヒルの学位を持ち、サフラ子供病院およびトロント大学での経験があります。主なポイントには以下が含まれます：

• 小児感染症の専門
• ダナ＝ドウェク小児病院における小児感染症サービスのディレクター
• マルゼ・バヒルの学位
• サフラ子供病院およびトロント大学での経験

Education

GATA Haydarpaşa Training and Research Hospital Istanbul, Turkey

Residency program Sep 2011

Infectious Diseases and Clinical Microbiology Department fellowship program.

Gülhane Military Medical Academy Ankara, Turkey

Bachelor of Science: Medical School Aug 2003

Kuleli Military High School Istanbul, Turkey

High School Diploma Jul 1997

Experience

Health Sciences University Istanbul, Turkey

Associated Professor of Infectious Diseases Aug 2021 - Current

Associated Professor

Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey

Infectious Diseases Physician July 2020–August 2021

Infectious Diseases Physician

Yale School of Medicine Infectious Diseases Department New Haven, CT, USA

Associate Research Scientist June 2019- June2020

Research to improve vaccine against Tick Borne Diseases (Lyme Diseases, Babesiosis etc.)

Yale School of Medicine Infectious Diseases Department New Haven, CT, USA

Visiting Research Scientist Jul 2018 - June2019

Research to improve vaccine against Tick Borne Diseases (Lyme Diseases, Babesiosis etc.)

Turkish Ministry of Health Ankara, Turkey

Head of Health Tourism unit Feb 2017 - June 2018

Improving the health tourism policy of Turkey.

Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey

Infectious Diseases Physician Aug 2016 - June 2018

Infectious Diseases Physician

Tatvan Military Hospital Bitlis , Turkey

Infectious Diseases Physician Jul 2013 - Aug 2016

Infectious Diseases physician

Girne Military Hospital Turkish Republic of Northern Cyprus

Infectious Diseases Physician Oct 2011 - Jun 2013

Infectious diseases physician

GATA Training and Research Hospital Istanbul, Turkey

Residency period Jul 2006 - Sep 2011

4 th. Mechanized Infantry Brigade Command Edirne, Kesan, Turkey

Medical Doctor, May 2004 - Jun 2006

Maintaining the basic health services of the military unit.

Dr. Gorpong Koowattanataworn, MD, is board-certified in Anti-Aging & Regenerative Medicine (A4M/ABAARM). He earned his MD from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University. He holds a Master’s in Management in Health and Preventive Medicine from Mahidol University. He also holds a Master’s in Anti-Aging & Regenerative Medicine from Mae Fah Luang University. He has a Diploma in Occupational Medicine from Burapha University. He is certified in Practical Stem Cell Therapy (Thai Association of Cell Therapy) and in Chelation Therapy.

Specialties: anti-aging and regenerative medicine; preventive and lifestyle medicine; aesthetic dermatology; cell and stem-cell therapies (MSCs for knee restoration, exosome/MSC therapies); hormone management and bioidentical HRT; cancer immunotherapy (NK cell boosters); weight management; personalized compounded supplements; gut and immune health; men’s sexual health; chelation therapy.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Experience

2017 - 2020 Acıpayam State Hospital

2016 - 2017 Izmir Public Health Laboratory

2013 - 2016 Bozyaka Training and Research Hospital

2011 - 2013 Pendik State Hospital

2011 - 2011 Midyat State Hospital

2004 - 2010 Dokuz Eylul University Faculty of Medicine

Acipayam State Hospital

Izmir Public Health Laboratory

Bozyaka Training and Research Hospital

Pendik State Hospital

Midyat State Hospital

Dokuz Eylul University Faculty of Medicine

Education

2010 Dokuz Eylul University Faculty of Medicine, Infectious Diseases and Clinical Microbiology

2010 Dokuz Eylul University Faculty of Medicine, Infectious Diseases and Clinical Microbiology

2004 Ege University, Faculty of Medicine

2004 Ege University, Faculty of Medicine

Publications

ARTICLES PUBLISHED IN INTERNATIONAL REFEREED JOURNALS

Bulent Ertugrul, Çağrı Buke, Özlem Saylak Ersoy, Bengisu Ay, Dilek Senen Demirez, Öner Savk. Intralesional epidermal growth factor for diabetic foot wounds: the first cases in Turkey. Diabetic foot and ankle.6: August 2015

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study. Journal of Diabetes and its Complications, Volume 30, Issue 5, July 2016,910-916

Alpay Arı, Ali Ilgın Olut, Bengisu Ay, Selma Tosun, Meltem Zencir, Mehmet Umut Çayıröz. A small outbreak of Serratia liquefaciens bacteremia due to use of contaminated saline infusion solution for myocardial perfusion scintigraphy. Journal of Infectious Diseases, Volume 49, 2017, 639-40

B- PAPERS PRESENTED IN INTERNATIONAL SCIENTIFIC CONFERENCES AND PUBLISHED IN PROCEEDINGS

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Current Bacterial Etiology And Antimicrobial Resistance In Dfıs; A Multicenter Prospective Trial Of “Turk-Day”. Congress of Balkan Millitary Medical Committee, 8-11 June 2015, Greece

C- ARTICLES PUBLISHED IN NATIONAL REFEREED JOURNALS

VildanAvkan Oğuz, Bengisu Ay, Vasfi Karatosun, Zeynep Gülay; A Case of Total Knee Arthroplasty in which Aeromonas Hydrophila Was Isolated in Perioperative Culture: Trakya Univ Medical Faculty Journal, 2009

Şebnem Çalık, Bengisu Kara Ay, Arif Yüksel, Kamuran Çapcıoğlu, Meltem Zencir, Ümran Bingöl, Neslihan Genç, Meltem Avcı, Selma Tosun. Evaluation of the knowledge level and vaccination status of individuals in the risk group recommended for influenza vaccination. Medical Journal of İzmir Hospital 2013; 17 (4): 241-245

B Ay, S Calik, B Karaca, S Tosun. Atypical Mediterranean spotted fever: First case from Aegean Region. Izmir Tepecik Education and Research Hospital Journal. 2016; 26(2):175-177

B Ay, E Ozdemir, N Unel, S Calik, B Karaca. Telbivudine-Related Myopathy: A Case Report. Viral Hepat J 2016; 22: 37-38

D- PAPERS PRESENTED IN NATIONAL SCIENTIFIC MEETINGS AND PUBLISHED IN PROCEEDINGS

Şebnem Çalık, Bengisu Kara Ay, Arif Yüksel, Kamuran Çapcıoğlu, Meltem Zencir, Ümran Bingöl, Neslihan Genç, Meltem Avcı, Selma Tosun. Evaluation of the knowledge level and vaccination status of individuals in the risk group who are recommended to receive influenza vaccination. 5th National Vaccine Symposium, 25-29 September 2013, Ankara

''Evaluation of 4 Patients Receiving Telaprevir for Chronic Hepatitis C'' “Speech 7" Istanbul – Marriott Asia Hotel; 'Our Turkey Teleprevir Experience Symposium, 21 September 2013'

Bengisu Ay, Alpay Arı, Nalan Ünel, Erman Özdemir, Selma Tosun; Our experience with telaprevir in two centers: 12th National Viral Hepatitis Congress, 26-29 March 2014, Belek/Antalya

Bengisu Ay, Erman Özdemir, Nalan Ünel; Myopathy side effect of telbivudine treatment due to a case: 12th National Viral Hepatitis Congress, 26-29 March 2014, Belek/Antalya

Gülsüm Altın, Aslı Keleş, Bengisu Ay, Ebru Dik, Meltem Zencir, Halil Erkan, Selma Tosun. Evaluation of the differences and knowledge levels of individuals in the society about the transmission routes of Hepatitis B virus. BUHASDER 6. Tepecik Infection Days Symposium. 04-08 November 2015 Muğla.

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Current Causative Microorganisms and Antimicrobial Susceptibilities in Diabetic Foot Infection; A Multicenter Study “TURK-DAY”. 5th EKMUD Scientific Platform, 01-04 April 2015, İzmir.

Dr. Antonia Artigues-Barcelo is an experienced Internal Medicine Consultant with over 20 years in the field. She earned her medical degree from Universitat Autònoma de Barcelona. She completed her Internal Medicine training at Hospital Universitario Son Dureta. She also specialized in Autoimmune Systemic Diseases at Hospital Clinic de Barcelona in 1998.

Dr. Artigues-Barcelo is registered with the GMC in Spain. She works as an Adjunct Clinical Associate Professor of Internal Medicine at MBRU Dubai. She has helped develop specialized units for Autoimmune Systemic Diseases and Palliative Care. She also has expertise in infectious diseases and antimicrobial treatment, certified by Cardinal Herrera University CEU.

Prof. Dr. Ali İnal is a physician with over 25 years of experience. He specializes in Clinical Microbiology, Infectious Diseases, Immunology, and Allergy. He works as a Professor in the Department of Immunology and Allergy at Başkent University Istanbul Hospital.

Dr. İnal completed his training in Clinical Microbiology and Infectious Diseases. He also finished a fellowship in Clinical Immunology and Allergy. He has managed Immunology and Tissue Typing Laboratories for more than 20 years. He has played a key role in improving transplant immunology and diagnostic immunology services.

His research covers cytokine storms in COVID-19, donor-specific antibodies, transplant rejection, autoimmunity, and primary immunodeficiencies. Dr. İnal has published many scientific articles. He has received research awards and grants. He also takes part in national and international congresses.

Education

• Undergraduate: Ankara University 1997-2003
• Residency: Ankara Dr. Sami Ulus Children's Hospital Pediatrics 2003-2009
• Subspecialization: Marmara University Faculty of Medicine Pediatric Infectious Diseases 2009-2013

Experience

• Interuniversity Council 2017
• Marmara University Faculty of Medicine 2018-2019
• Marmara University Faculty of Medicine 2019-2023
• Bahcesehir University Faculty of Medicine 2024
• Biruni University Faculty of Medicine 2024- present

He graduated from Ankara University Faculty of Medicine in 2003, completed his specialization in Pediatrics at Ankara Dr. Sami Ulus Children's Hospital in 2009, and completed his subspecialization in Pediatric Infectious Diseases at Marmara University Faculty of Medicine, Department of Pediatric Infectious Diseases in 2013. He has contributed to the education of many medical students, pediatric residents and subspecialty residents within Marmara University Faculty of Medicine. He trained 8 pediatric infectious diseases subspecialists between 2018 and 2023 as the Head of the Department. Tuberculosis disease, HIV infection, prevention and treatment of infections in children with immune defects, healthcare-associated infections, vaccine-preventable diseases in children, Covid-19 Pandemic management.He has participated as a member of many commissions, as a researcher in projects and as an author in consensus guidelines and has provided patient care services on these issues in the clinics where he works.In our country, he prepares 'Rational Antibiotic Use' training materials and provides training to family physicians and pediatricians on this subject.

Medical Intrests

• 
  Fire
• Vaccines
• Upper and lower respiratory tract infections
• Child with diarrhoea
• Rash diseases
• Tuberculosis
• Skin and soft tissue infections
• HIV infection

The doctor analyzes the patient's health condition, taking into account his physical, social and psychological characteristics. Selects the optimal treatment and monitors its implementation, and also ensures long-term monitoring of the patient's health. Organizes consultations with specialized specialists, refers for laboratory tests and diagnostic procedures, conducts preventive and explanatory work with the patient and his family.

The doctor treats such diseases as anaphylactic shock, arterial hypertension, ischemic heart disease, angina pectoris, chronic obstructive pulmonary disease. Also treats cystitis, gastritis and acute respiratory viral infection.